These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29876504)

  • 1. Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives.
    Merlo M; Caiffa T; Gobbo M; Adamo L; Sinagra G
    Int J Cardiol Heart Vasc; 2018 Mar; 18():52-57. PubMed ID: 29876504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management of dilated cardiomyopathy: current knowledge and future perspectives.
    Merlo M; Cannatá A; Vitagliano A; Zambon E; Lardieri G; Sinagra G
    Expert Rev Cardiovasc Ther; 2016; 14(2):137-40. PubMed ID: 26606394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone Modification Is Correlated With Reverse Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy.
    Ito E; Miyagawa S; Fukushima S; Yoshikawa Y; Saito S; Saito T; Harada A; Takeda M; Kashiyama N; Nakamura Y; Shiozaki M; Toda K; Sawa Y
    Ann Thorac Surg; 2017 Nov; 104(5):1531-1539. PubMed ID: 28760462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular reverse remodeling with infantile dilated cardiomyopathy and pitfalls of carvedilol therapy.
    Tsuda E; Negishi J; Noritake K; Iwasa T; Abe T
    J Cardiol; 2016 Feb; 67(2):147-52. PubMed ID: 26572957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Blood Pressure and Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy with Spontaneous Mechanical Alternans.
    Watanabe M; Kashimura T; Ishizuka M; Kase M; Sakai R; Fujiki S; Takayama T; Ishihara S; Ozaki K; Inomata T
    Intern Med; 2023 Jun; 62(12):1707-1713. PubMed ID: 36351583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dilated cardiomyopathy: a dynamic disease - clinical course, reverse remodeling and prognostic stratification].
    Merlo M; Gigli M; Poli S; Stolfo D; Brun F; Lardieri G; Pinamonti B; Zecchin M; Pivetta A; Vitrella G; Di Lenarda A; Sinagra G
    G Ital Cardiol (Rome); 2016 Jan; 17(1):15-23. PubMed ID: 26901255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural History of MYH7-Related Dilated Cardiomyopathy.
    de Frutos F; Ochoa JP; Navarro-Peñalver M; Baas A; Bjerre JV; Zorio E; Méndez I; Lorca R; Verdonschot JAJ; García-Granja PE; Bilinska Z; Fatkin D; Fuentes-Cañamero ME; García-Pinilla JM; García-Álvarez MI; Girolami F; Barriales-Villa R; Díez-López C; Lopes LR; Wahbi K; García-Álvarez A; Rodríguez-Sánchez I; Rekondo-Olaetxea J; Rodríguez-Palomares JF; Gallego-Delgado M; Meder B; Kubanek M; Hansen FG; Restrepo-Córdoba MA; Palomino-Doza J; Ruiz-Guerrero L; Sarquella-Brugada G; Perez-Perez AJ; Bermúdez-Jiménez FJ; Ripoll-Vera T; Rasmussen TB; Jansen M; Sabater-Molina M; Elliot PM; Garcia-Pavia P;
    J Am Coll Cardiol; 2022 Oct; 80(15):1447-1461. PubMed ID: 36007715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The right ventricular involvement in dilated cardiomyopathy: prevalence and prognostic implications of the often-neglected child.
    Manca P; Nuzzi V; Cannatà A; Castrichini M; Bromage DI; De Luca A; Stolfo D; Schulz U; Merlo M; Sinagra G
    Heart Fail Rev; 2022 Sep; 27(5):1795-1805. PubMed ID: 35315505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance.
    Mitropoulou P; Georgiopoulos G; Figliozzi S; Klettas D; Nicoli F; Masci PG
    Front Cardiovasc Med; 2020; 7():97. PubMed ID: 32714942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy.
    Verdonschot JAJ; Hazebroek MR; Wang P; Sanders-van Wijk S; Merken JJ; Adriaansen YA; van den Wijngaard A; Krapels IPC; Brunner-La Rocca HP; Brunner HG; Heymans SRB
    Circ Heart Fail; 2018 Nov; 11(11):e005220. PubMed ID: 30571196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
    Sarli B; Topsakal R; Kaya EG; Akpek M; Lam YY; Kaya MG
    J Investig Med; 2013 Apr; 61(4):728-32. PubMed ID: 23429699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction.
    Muhammed A; Abdelazeem M; Elewa MG; Sharief M; Ammar A
    Heart Fail Rev; 2023 Jan; 28(1):229-240. PubMed ID: 35587303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis.
    Becker MAJ; Cornel JH; van de Ven PM; van Rossum AC; Allaart CP; Germans T
    JACC Cardiovasc Imaging; 2018 Sep; 11(9):1274-1284. PubMed ID: 29680351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving concepts in dilated cardiomyopathy.
    Merlo M; Cannatà A; Gobbo M; Stolfo D; Elliott PM; Sinagra G
    Eur J Heart Fail; 2018 Feb; 20(2):228-239. PubMed ID: 29271570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Atrial Reverse Remodeling in Dilated Cardiomyopathy.
    Nuzzi V; Raafs A; Manca P; Henkens MTHM; Gregorio C; Boscutti A; Verdonschot J; Hazebroek M; Knackstedt C; Merlo M; Stolfo D; Sinagra G; Heymans SRB
    J Am Soc Echocardiogr; 2023 Feb; 36(2):154-162. PubMed ID: 36332803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in left ventricular curvature and principal strains in dilated cardiomyopathy with functional mitral regurgitation.
    Tibayan FA; Lai DT; Timek TA; Dagum P; Liang D; Zasio MK; Daughters GT; Miller DC; Ingels NB
    J Heart Valve Dis; 2003 May; 12(3):292-9. PubMed ID: 12803327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
    Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current perspectives on the diagnosis and management of dilated cardiomyopathy Beyond heart failure: a Cardiomyopathy Clinic Doctor's point of view.
    Bakalakos A; Ritsatos K; Anastasakis A
    Hellenic J Cardiol; 2018; 59(5):254-261. PubMed ID: 29807197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy in women with dilated cardiomyopathy.
    Bangi EF; Maikawa N; Kaur A; Jain R; Jain R
    Future Cardiol; 2022 Aug; 18(8):661-667. PubMed ID: 35549709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.